dihexa iupac name Dihexa | 1401708-83-5 | BGC70883

Phase 2b doses were 0.25 to 1.0 mg daily, which at a 2.5 mg/ml concentration means 0.1 to 0.4 ml per injection, conveniently measurable on a 1 ml insulin syringe

Quick support, thoughtful screening

BPC-157 for neuropathy and nerve regeneration BPC-157 stands as arguably the most researched peptide for peripheral nerve regeneration, with a body of preclinical evidence that spans multiple nerve injury models, administration routes, and outcome measures

Check if the correct dosage is still in the syringe after removing air bubbles

Unopened vials are stable at room temperature

Overall, it provides a reliable and efficient way to explore research in controlled research environments